In summary, we found that the iPSC-HLCs derived from the stable CAD patients had a distinct genetic miRNA profile that could influence lipid metabolism, sphingolipid and insulin signalling as well as inflammation processes. This evidence concerns the gene INS and coronary artery disorder.